Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,066 | 16 | 91.4% |
| Education | $99.99 | 1 | 8.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Davol Inc. | $257.53 | 2 | $0 (2023) |
| Bard Peripheral Vascular, Inc. | $177.80 | 1 | $0 (2018) |
| Inari Medical, Inc. | $128.00 | 1 | $0 (2024) |
| Merck Sharp & Dohme LLC | $126.71 | 2 | $0 (2024) |
| Astellas Pharma US Inc | $119.68 | 2 | $0 (2024) |
| Travere Therapeutics, Inc. | $104.58 | 1 | $0 (2024) |
| KCI USA, Inc | $83.79 | 1 | $0 (2019) |
| Mallinckrodt Hospital Products Inc. | $51.48 | 2 | $0 (2024) |
| Veloxis Pharmaceuticals, Inc. | $42.74 | 2 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $32.11 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $627.38 | 12 | Inari Medical, Inc. ($128.00) |
| 2023 | $276.78 | 3 | Davol Inc. ($257.53) |
| 2019 | $83.79 | 1 | KCI USA, Inc ($83.79) |
| 2018 | $177.80 | 1 | Bard Peripheral Vascular, Inc. ($177.80) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $30.65 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: TRANSPLANTATION | ||||||
| 10/09/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 07/17/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: IMMUNOLOGY | ||||||
| 07/03/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 06/27/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Infectious Diseases | ||||||
| 06/05/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $104.58 | General |
| 06/02/2024 | Merck Sharp & Dohme LLC | PREVYMIS (Drug) | Food and Beverage | In-kind items and services | $97.64 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/10/2024 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: TRANSPLANTATION | ||||||
| 04/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $32.11 | General |
| Category: IMMUNOLOGY | ||||||
| 03/07/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $128.00 | General |
| Category: VTE | ||||||
| 02/21/2024 | Merck Sharp & Dohme LLC | PREVYMIS (Drug), DIFICID | Food and Beverage | In-kind items and services | $29.07 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/29/2023 | Davol Inc. | Phasix Mesh (Device) | Food and Beverage | In-kind items and services | $123.50 | General |
| Category: Surgery | ||||||
| 08/04/2023 | LeMaitre Vascular, Inc. | ARTEGRAFT VASCULAR GRAFT (Device) | Food and Beverage | Cash or cash equivalent | $19.25 | General |
| Category: ARTEGRAFT | ||||||
| 03/29/2023 | Davol Inc. | Phasix Mesh (Device) | Food and Beverage | In-kind items and services | $134.03 | General |
| Category: Surgery | ||||||
| 09/24/2019 | KCI USA, Inc | PREVENA (Device), VAC VERAFLO | Food and Beverage | In-kind items and services | $83.79 | General |
| Category: NON-COVERED | ||||||
| 11/21/2018 | Bard Peripheral Vascular, Inc. | FLAIR (Device) | Food and Beverage | In-kind items and services | $177.80 | General |
| Category: VASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 234 | 281 | $899,232 | $77,131 |
| 2022 | 16 | 473 | 551 | $1.9M | $146,190 |
| 2021 | 16 | 466 | 528 | $1.6M | $154,246 |
| 2020 | 13 | 421 | 514 | $1.4M | $142,222 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 50360 | Transplantation of donor kidney | Facility | 2023 | 19 | 19 | $347,400 | $31,758 | 9.1% |
| 36831 | Removal of blood clot from hemodialysis graft | Facility | 2023 | 22 | 27 | $107,109 | $11,553 | 10.8% |
| 36832 | Revision of hemodialysis graft | Facility | 2023 | 20 | 20 | $83,520 | $10,721 | 12.8% |
| 36833 | Revision of hemodialysis graft with removal of blood clot | Facility | 2023 | 11 | 12 | $56,784 | $5,827 | 10.3% |
| 36902 | Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | Facility | 2023 | 28 | 31 | $146,382 | $5,411 | 3.7% |
| 37607 | Tying or banding of surgically created artery-vein connection | Facility | 2023 | 14 | 15 | $33,405 | $3,944 | 11.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 33 | $11,550 | $2,972 | 25.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 14 | $7,280 | $1,838 | 25.2% |
| 50323 | Preparation of donor kidney for transplantation | Facility | 2023 | 16 | 16 | $58,656 | $1,216 | 2.1% |
| 36907 | Balloon dilation of dialysis segment with review by radiologist | Facility | 2023 | 11 | 11 | $30,712 | $1,114 | 3.6% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 66 | 83 | $16,434 | $778.54 | 4.7% |
| 50360 | Transplantation of donor kidney | Facility | 2022 | 45 | 45 | $815,400 | $71,727 | 8.8% |
| 36832 | Revision of hemodialysis graft | Facility | 2022 | 27 | 33 | $139,061 | $17,906 | 12.9% |
| 36831 | Removal of blood clot from hemodialysis graft | Facility | 2022 | 21 | 24 | $95,208 | $9,983 | 10.5% |
| 36902 | Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | Facility | 2022 | 38 | 43 | $202,331 | $7,678 | 3.8% |
| 36830 | Creation of artery-vein connection using tube graft for hemodialysis | Facility | 2022 | 15 | 15 | $84,030 | $7,354 | 8.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 51 | 51 | $26,520 | $7,343 | 27.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 32 | 68 | $23,800 | $5,264 | 22.1% |
| 37607 | Tying or banding of surgically created artery-vein connection | Facility | 2022 | 19 | 19 | $44,317 | $5,094 | 11.5% |
| 50323 | Preparation of donor kidney for transplantation | Facility | 2022 | 44 | 44 | $161,304 | $3,604 | 2.2% |
| 49422 | Removal of abdominal cavity tube | Facility | 2022 | 16 | 16 | $35,488 | $2,500 | 7.0% |
| 36907 | Balloon dilation of dialysis segment with review by radiologist | Facility | 2022 | 18 | 18 | $50,256 | $1,977 | 3.9% |
| 50327 | Preparation of donor kidney and veins for transplantation | Facility | 2022 | 20 | 20 | $97,060 | $1,720 | 1.8% |
| 36901 | Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | Facility | 2022 | 11 | 11 | $25,509 | $1,398 | 5.5% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2022 | 94 | 122 | $24,156 | $1,153 | 4.8% |
About Dr. Angello Lin, MD
Dr. Angello Lin, MD is a Transplant Surgery healthcare provider based in Augusta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184647760.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Angello Lin, MD has received a total of $1,166 in payments from pharmaceutical and medical device companies, with $627.38 received in 2024. These payments were reported across 17 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,066).
As a Medicare-enrolled provider, Lin has provided services to 1,594 Medicare beneficiaries, totaling 1,874 services with total Medicare billing of $519,788. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Transplant Surgery
- Other Specialties Transplant Surgery
- Location Augusta, GA
- Active Since 07/25/2006
- Last Updated 03/12/2024
- Taxonomy Code 204F00000X
- Entity Type Individual
- NPI Number 1184647760
Products in Payments
- Phasix Mesh (Device) $257.53
- FLAIR (Device) $177.80
- FLOWTRIEVER CATHETER, S (Device) $128.00
- PREVYMIS (Drug) $126.71
- PREVENA (Device) $83.79
- ACTHAR (Biological) $51.48
- ENVARSUS (Drug) $42.74
- LIVTENCITY (Drug) $32.11
- Crysvita (Drug) $22.08
- Cresemba (Drug) $19.69
- ARTEGRAFT VASCULAR GRAFT (Device) $19.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.